Related Experiment Video

Updated: Jun 17, 2026

Two- and Three-Dimensional Live Cell Imaging of DNA Damage Response Proteins
10:24

Two- and Three-Dimensional Live Cell Imaging of DNA Damage Response Proteins

Published on: September 28, 2012

New insights into checkpoint kinase 1 in the DNA damage response signaling network

Yun Dai1, Steven Grant

  • 1Department of Medicine, Institute for Molecular Medicine, and Division of Hematology/Oncology, Department of Medicine, Virginia Commonwealth University Massey Cancer Center, Richmond, Virginia 23298, USA.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|January 14, 2010
PubMed

Insights

The DNA damage response (DDR) network is crucial for maintaining genomic integrity. Targeting checkpoint kinase 1 (Chk1) within the DDR offers new strategies for cancer therapy by potentially enhancing treatment efficacy.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Biology

Background:

  • The DNA damage response (DDR) is a complex signaling network essential for maintaining genomic stability against various stresses.
  • The DDR impacts cancer treatment efficacy by influencing cellular responses to genotoxic agents and radiation.
  • Checkpoint kinase 1 (Chk1) is a key regulator within the DDR, involved in multiple cell cycle checkpoints.

Purpose of the Study:

  • To explore the multifaceted role of Chk1 in the DNA damage response.
  • To evaluate the potential of Chk1 as a therapeutic target in cancer treatment.
  • To identify novel strategies for developing Chk1 inhibitors.

Main Methods:

  • Review of existing literature on DDR signaling pathways.
  • Analysis of Chk1's involvement in cell cycle checkpoints, DNA repair, and apoptosis.
  • Exploration of therapeutic implications of targeting Chk1.

Main Results:

  • Chk1 plays a central role in the DDR, regulating cell cycle checkpoints.
  • New insights reveal Chk1's direct involvement in DNA repair and apoptotic processes.
  • The efficacy of current Chk1 inhibitors in enhancing cancer therapy is still under investigation.

Conclusions:

  • Chk1 is a critical component of the DDR machinery, extending beyond checkpoint regulation.
  • Understanding Chk1's comprehensive role opens avenues for innovative therapeutic strategies.
  • Targeting Chk1 presents a promising opportunity for developing novel cancer treatments.

More Related Videos

Detection and Visualization of DNA Damage-induced Protein Complexes in Suspension Cell Cultures Using the Proximity Ligation Assay13:10

Detection and Visualization of DNA Damage-induced Protein Complexes in Suspension Cell Cultures Using the Proximity Ligation Assay

Published on: June 9, 2017

Laser Microirradiation to Study In Vivo Cellular Responses to Simple and Complex DNA Damage10:44

Laser Microirradiation to Study In Vivo Cellular Responses to Simple and Complex DNA Damage

Published on: January 31, 2018

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...